Comparison of Cerebrolysin and Donepezil: A Randomized, Double-blind, Controlled Trial on Efficacy and Safety in Patients With Mild to Moderate Alzheimer's Disease
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 05 Nov 2015
At a glance
- Drugs Brain extract (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors EVER Neuro Pharma
- 10 Jun 2017 Biomarkers information updated
- 23 Oct 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 03 Apr 2014 Planned initiation date changed from 1 Sep 2013 to 1 Jul 2014 as reported by ClinicalTrials.gov record.